PAR 0.00% 19.5¢ paradigm biopharmaceuticals limited..

This was the best I could find without subscription:08 May 2018...

  1. 516 Posts.
    lightbulb Created with Sketch. 43

    This was the best I could find without subscription:

    08 May 2018 Consilient Health and bene-Arzneimittel GmbH signs distribution agreement to distribute Pentosan polysulfate sodium in the United Kingdom
    08 Feb 2018 Discontinued - Phase-II for Spinal cord disorders in Japan (SC)
    08 Dec 2017 Phase-II clinical trials in Osteoarthritis (In children) in Japan (SC) (UMIN000032119)
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.